Johnson & Johnson is looking to sell its Cerenovus stroke therapy business, according three unnamed people "with knowledge of ...

To give some idea of the sheer size of Johnson & Johnson, a glance at its reported sales figure is revealing. In the fourth ...

Good morning and welcome to Johnson & Johnson's Fourth Quarter 2024 ... pumps to treat pediatric patients and FDA clearance of Shockwave's Javelin Peripheral IVL Catheter for the treatment of ...

Johnson & Johnson has put its stroke care business up for sale, aiming for a valuation of more than $1bn, as part of its ...

Here's the skinny on that quarter and whether the rest of the year will be healthy enough to rank the company's stock as a buy. To give some idea of the sheer size of Johnson & Johnson ...

We take a look at how DeepSeek's AI disruption sent a $593 billion shockwave to Nvidia ... which houses bellwethers like Johnson & Johnson, Procter & Gamble Co. and Coca-Cola Co. saw big boost.

Johnson & Johnson (NYSE: JNJ) didn't have an exceptional 2024; in fact, it was one of the worst-performing stocks on the vaunted, 30-company Dow Jones Industrial Average that year. Yet, if the ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.